WeVote
Log In

Bill

Bill

SJR 16

Relating to: recognizing May 1 of each year as St. Joseph the Worker Day in Wisconsin and recognizing and appreciating the dignity of all working men and women in Wisconsin.

2025-2026 Regular Session Introduced by André Jacque and 2 co-sponsors

Designates October as Eczema Awareness Month in New Jersey, urges a yearly gubernatorial proclamation to boost awareness and education, with no new funding.

Report correctly enrolled
0
WeVote Research Nonpartisan
Bill Summary · SJR 16

Summary — SJR 16 (Joint Resolution)

Designates October of each year as “Eczema Awareness Month” in New Jersey

Purpose / Intent

SJR 16 is a commemorative joint resolution intended to increase public awareness of eczema — a group of chronic skin conditions — and to promote understanding, support, and educational activities for people living with the condition in New Jersey.

Key provisions

  • Designates October of each year as “Eczema Awareness Month” in New Jersey.
  • Requests that the Governor annually issue a proclamation designating October as Eczema Awareness Month and call upon public officials and citizens to observe the month with appropriate activities and programs.
  • Directs that copies of the resolution, as filed with the Secretary of State, be transmitted to the National Eczema Association.
  • Provides that the resolution takes effect immediately.

Background / Context included in the resolution

  • Defines eczema (red, itchy, inflamed skin) and lists common symptoms and triggers (stress, sweat, soaps/detergents, allergens).
  • Notes that eczema often appears in childhood but can present at any age; it can be episodic with flare-ups.
  • Cites prevalence estimates: roughly 32+ million Americans affected, ~10% national prevalence and over 13% prevalence in New Jersey.
  • Mentions common treatments (bathing/moisturizing routines, OTC and prescription topical meds, phototherapy, immunosuppressants, biologics, and alternative treatments).
  • References the American Academy of Dermatology estimate that treatment and related costs may be as high as $3.8 billion per year and highlights the social and emotional burden (stigma, social avoidance, depression, sleep loss).

Who is affected / likely impact

  • Primarily symbolic: individuals with eczema, patient and advocacy groups (e.g., National Eczema Association), health care providers, schools, community organizations, and the general public.
  • No regulatory or funding changes: the resolution does not create new rights, obligations, programs, or appropriations. Its primary effect is awareness-raising and encouraging voluntary activity and outreach.
  • Potential indirect benefits: increased public awareness could lead to greater education, reduced stigma, and support for research and access to care, but none are mandated by the resolution.

Legislative status and sponsors

  • Classification: Joint resolution (ceremonial/commemorative).
  • Introduced: November 12, 2024.
  • Status (as provided): Introduced in the Senate and referred to the Senate Health, Human Services and Senior Citizens Committee.
  • Primary sponsors: Senator Crowell and Representative McNair (and others listed in the document).
  • Effectiveness: takes effect immediately upon adoption.

Note: This is a commemorative resolution rather than a statute — it encourages proclamation and observance but does not create legal entitlements or fund programs.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.